Simplex Trading’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-62,400
| Closed | -$2.09M | – | 10223 |
|
|
2026
Q1 | $2.09M | Buy |
62,400
+52,600
| +537% | +$2.06M | ﹤0.01% | 1779 |
|
|
2025
Q4 | $454K | Sell |
9,800
-75,000
| -88% | -$4.11M | ﹤0.01% | 3395 |
|
|
2025
Q3 | $5.73M | Buy |
84,800
+12,600
| +17% | +$934K | ﹤0.01% | 1342 |
|
|
2025
Q2 | $6.05M | Sell |
72,200
-110,100
| -60% | -$8.24M | ﹤0.01% | 1206 |
|
|
2025
Q1 | $13M | Buy |
182,300
+120,100
| +193% | +$5.85M | 0.01% | 724 |
|
|
2024
Q4 | $2.79M | Buy |
62,200
+36,500
| +142% | +$1.89M | ﹤0.01% | 1915 |
|
|
2024
Q3 | $1.3M | Buy |
25,700
+15,500
| +152% | +$742K | ﹤0.01% | 2676 |
|
|
2024
Q2 | $416K | Buy |
10,200
+3,800
| +59% | +$161K | ﹤0.01% | 3846 |
|
|
2024
Q1 | $273K | Buy |
6,400
+5,300
| +482% | +$240K | ﹤0.01% | 4507 |
|
|
2023
Q4 | $44K | Buy |
+1,100
| New | +$31.3K | ﹤0.01% | 6207 |
|
|
2022
Q1 | – | Sell |
-1,427
| Closed | -$8K | – | 11311 |
|
|
2021
Q4 | $8K | Sell |
1,427
-1,846
| -56% | -$19.4K | ﹤0.01% | 9222 |
|
|
2021
Q3 | $54K | Buy |
3,273
+6
| +0.2% | +$84 | ﹤0.01% | 7430 |
|
|
2021
Q2 | $55K | Buy |
3,267
+3,260
| +46,571% | +$55.1K | ﹤0.01% | 7538 |
|
|
2021
Q1 | $12K | Buy |
7
+6
| +600% | +$193 | ﹤0.01% | 7807 |
|
|
2020
Q4 | $2K | Sell |
1
-6
| -86% | -$173 | ﹤0.01% | 8009 |
|
|
2020
Q3 | $24K | Sell |
7
-9
| -56% | -$263 | ﹤0.01% | 6256 |
|
|
2020
Q2 | $51K | Buy |
+16
| New | +$693 | ﹤0.01% | 5480 |
|
Simplex Trading's SLNO Position: Q2 2026 in Review
Simplex Trading sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 18,166 shares — an estimated $608K sold.
Simplex Trading first reported a position in SLNO in Q4 2020 and held it in 10 quarters. The position peaked at $2.27M in Q4 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.
- Simplex Trading reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
- Simplex Trading sold 18,166 Soleno Therapeutics shares in Q2 2026, an estimated $608K.
- Simplex Trading first reported a position in Soleno Therapeutics in Q4 2020 and held it in 10 quarters.
- Simplex Trading's Soleno Therapeutics position peaked at $2.27M in Q4 2025.
- 0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.